Flagship Harbor Advisors LLC Has $753,000 Position in McKesson Corporation $MCK

Flagship Harbor Advisors LLC lowered its position in McKesson Corporation (NYSE:MCK) by 40.2% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 917 shares of the company’s stock after selling 616 shares during the period. Flagship Harbor Advisors LLC’s holdings in McKesson were worth $753,000 at the end of the most recent reporting period.

Other hedge funds have also recently added to or reduced their stakes in the company. Alliancebernstein L.P. grew its holdings in McKesson by 150.4% during the second quarter. Alliancebernstein L.P. now owns 2,268,015 shares of the company’s stock valued at $1,661,956,000 after purchasing an additional 1,362,386 shares during the last quarter. DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main grew its holdings in McKesson by 45.6% during the second quarter. DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main now owns 833,780 shares of the company’s stock valued at $610,977,000 after purchasing an additional 261,296 shares during the last quarter. The Manufacturers Life Insurance Company grew its holdings in McKesson by 34.1% during the second quarter. The Manufacturers Life Insurance Company now owns 839,690 shares of the company’s stock valued at $615,305,000 after purchasing an additional 213,406 shares during the last quarter. SurgoCap Partners LP grew its holdings in McKesson by 68.7% during the third quarter. SurgoCap Partners LP now owns 452,261 shares of the company’s stock valued at $349,390,000 after purchasing an additional 184,106 shares during the last quarter. Finally, Danica Pension Livsforsikringsaktieselskab acquired a new position in McKesson during the third quarter valued at approximately $135,352,000. Institutional investors and hedge funds own 85.07% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities analysts have commented on the company. Robert W. Baird set a $968.00 price target on McKesson in a report on Wednesday, January 14th. Leerink Partners reiterated an “outperform” rating and set a $1,085.00 price target on shares of McKesson in a report on Thursday, March 5th. TD Cowen increased their price target on McKesson from $1,000.00 to $1,012.00 and gave the company a “buy” rating in a report on Thursday, February 5th. Barclays increased their price target on McKesson from $960.00 to $1,050.00 and gave the company an “overweight” rating in a report on Wednesday, February 18th. Finally, Evercore restated an “outperform” rating on shares of McKesson in a research note on Thursday, March 5th. Thirteen analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $970.93.

Insider Transactions at McKesson

In related news, CAO Napoleon B. Rutledge, Jr. sold 328 shares of the firm’s stock in a transaction on Friday, February 6th. The stock was sold at an average price of $955.00, for a total value of $313,240.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Michele Lau sold 2,725 shares of the firm’s stock in a transaction on Monday, March 2nd. The stock was sold at an average price of $990.00, for a total value of $2,697,750.00. Following the completion of the transaction, the executive vice president directly owned 3,247 shares of the company’s stock, valued at approximately $3,214,530. This trade represents a 45.63% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold 3,592 shares of company stock valued at $3,518,555 in the last ninety days. 0.08% of the stock is owned by company insiders.

McKesson Price Performance

Shares of MCK stock opened at $870.81 on Thursday. The stock has a market cap of $106.67 billion, a P/E ratio of 25.04, a price-to-earnings-growth ratio of 1.26 and a beta of 0.42. McKesson Corporation has a one year low of $637.00 and a one year high of $999.00. The stock has a fifty day moving average price of $914.48 and a 200 day moving average price of $849.12.

McKesson (NYSE:MCK) last issued its earnings results on Wednesday, February 4th. The company reported $9.34 EPS for the quarter, topping the consensus estimate of $9.19 by $0.15. The firm had revenue of $106.16 billion during the quarter, compared to analysts’ expectations of $105.98 billion. McKesson had a negative return on equity of 338.97% and a net margin of 1.09%.McKesson’s quarterly revenue was up 11.4% compared to the same quarter last year. During the same period last year, the business earned $8.03 earnings per share. McKesson has set its FY 2026 guidance at 38.800-39.200 EPS. Equities research analysts anticipate that McKesson Corporation will post 32.77 EPS for the current year.

McKesson Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Wednesday, April 1st. Investors of record on Monday, March 2nd were given a $0.82 dividend. This represents a $3.28 annualized dividend and a yield of 0.4%. The ex-dividend date of this dividend was Monday, March 2nd. McKesson’s dividend payout ratio (DPR) is 9.43%.

About McKesson

McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.